Hypothalamic–pituitary–somatotropic axis with growth hormone deficiency or Laron syndrome ( insensitivity) show symptoms like short stature, dwarfism and obesity, but are also protected from some forms of cancer. Conversely, acromegaly and gigantism are conditions of GH and IGF-1 excess usually due to a pituitary tumor, and are characterized by overgrowth and tall stature. Hypothalamic–pituitary–somatotropic axis The hypothalamic–pituitary–somatotropic axis (HPS axis), or hypothalamic–pituitary–somatic axis, also known as the hypothalamic–pituitary–growth axis, is a hypothalamic–pituitary axis which includes the secretion of growth hormone (GH; somatotropin) from the somatotropes of the pituitary gland into the circulation and the subsequent stimulation of insulin-like growth factor 1 (IGF-1;
Pituitary stalk tract. It has been thought that the pituitary stalk may become compressed due to suprasellar tumors in the pars tuberalis region, and that the resulting compression may cause hyperprolactinemia. This phenomenon has been described as the stalk effect or pituitary stalk compression syndrome. However, at least one article suggests that the increase in prolactin in these cases may instead be caused by the tumor's secretion of preprotachykinin A-derived tachykinins, substance P, and/or neurokinin A. Damage to the pituitary stalk blocks the release of antidiuretic hormone, resulting in polydypsia (abusive water intake) and polyuria (excessive urination). Pituitary stalk The pituitary stalk